CUE Latest Press Releases

-- December 19, 2025 --

Cue Biopharma Announces Pricing of $10 Million Public Offering Globe Newswire 8:00 AM

-- December 18, 2025 --

Cue Biopharma Announces Proposed Public Offering Globe Newswire 4:02 PM

-- November 13, 2025 --

Singapore-based ImmunoScape Pioneers Next-Generation Cell Therapy for Solid Tumors; Announces Key Licensing Deal, New Board and SAB Appointments Business Wire 1:11 PM

-- November 12, 2025 --

Cue Biopharma Reports Third Quarter 2025 Financial Results and Recent Business Highlights Globe Newswire 4:05 PM

-- November 6, 2025 --

Cue Biopharma and ImmunoScape Announce Strategic Collaboration to Develop Breakthrough Cell Therapy Approach for Solid Tumors Globe Newswire 8:00 AM

-- September 29, 2025 --

Cue Biopharma Announces Strategic Transition in Leadership to Further Enable Next Stage of Growth with Disruptive Autoimmune Therapeutic Candidates Globe Newswire 9:00 AM

-- August 21, 2025 --

Cue Biopharma to Participate in Fireside Chat at the Cantor Global Healthcare Conference Globe Newswire 8:00 AM

-- August 13, 2025 --

Cue Biopharma Announces Initiation of Investigator Sponsored Trial of CUE-102 in Recurrent Glioblastoma Multiforme Globe Newswire 8:00 AM

-- August 12, 2025 --

Cue Biopharma Reports Second Quarter 2025 Financial Results and Recent Business Highlights Globe Newswire 4:05 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software